How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
23
COSM Quote, Financials, Valuation and Earnings
Last price:
$0.47
Seasonality move
:
-11.8%
Day range:
$0.46 - $0.49
52-week range:
$0.28 - $1.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
0.73x
Volume:
457.8K
Avg. volume:
1M
1-year change:
-27.36%
Market cap:
$16.8M
Revenue:
$54.4M
EPS (TTM):
-$0.71
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
$22.8M | -$0.03 | 50.98% | -122.93% | $4.50 |
|
ENMI
DH Enchantment, Inc.
|
-- | -- | -- | -- | -- |
|
GEGP
Gold Entertainment Group, Inc.
|
-- | -- | -- | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$20.5M | -$0.01 | -54.41% | -72.53% | $1.55 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
$0.48 | $4.50 | $16.8M | -- | $0.00 | 0% | 0.22x |
|
ENMI
DH Enchantment, Inc.
|
$0.0001 | -- | $383.1K | -- | $0.00 | 0% | 0.29x |
|
GEGP
Gold Entertainment Group, Inc.
|
$0.0003 | -- | $2.3M | -- | $0.00 | 0% | 13.87x |
|
LAB
Standard BioTools, Inc.
|
$1.40 | $1.55 | $538.4M | -- | $0.00 | 0% | 4.12x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
51.13% | 3.902 | 68.41% | 1.30x |
|
ENMI
DH Enchantment, Inc.
|
220.68% | 6.827 | 9.65% | 1.00x |
|
GEGP
Gold Entertainment Group, Inc.
|
-184.79% | 197.169 | 26.04% | 0.03x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.680 | 5.49% | 1.93x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health, Inc.
|
$2.2M | -$1.8M | -44.07% | -68.76% | -10.63% | -$4M |
|
ENMI
DH Enchantment, Inc.
|
$132K | -$82.8K | -1574.1% | -- | -21.29% | -$71.4K |
|
GEGP
Gold Entertainment Group, Inc.
|
$17K | -$18.6K | -- | -- | -43.66% | -- |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
Cosmos Health, Inc. vs. Competitors
-
Which has Higher Returns COSM or ENMI?
DH Enchantment, Inc. has a net margin of -31.29% compared to Cosmos Health, Inc.'s net margin of -32.22%. Cosmos Health, Inc.'s return on equity of -68.76% beat DH Enchantment, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital COSMCosmos Health, Inc.13% -$0.17 $47.3M ENMIDH Enchantment, Inc.34.06% -- $1.4M -
What do Analysts Say About COSM or ENMI?
Cosmos Health, Inc. has a consensus price target of $4.50, signalling upside risk potential of 836.72%. On the other hand DH Enchantment, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cosmos Health, Inc. has higher upside potential than DH Enchantment, Inc., analysts believe Cosmos Health, Inc. is more attractive than DH Enchantment, Inc..
Company Buy Ratings Hold Ratings Sell Ratings COSMCosmos Health, Inc.0 0 0 ENMIDH Enchantment, Inc.0 0 0 -
Is COSM or ENMI More Risky?
Cosmos Health, Inc. has a beta of 4.381, which suggesting that the stock is 338.129% more volatile than S&P 500. In comparison DH Enchantment, Inc. has a beta of 2.221, suggesting its more volatile than the S&P 500 by 122.113%.
-
Which is a Better Dividend Stock COSM or ENMI?
Cosmos Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DH Enchantment, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cosmos Health, Inc. pays -- of its earnings as a dividend. DH Enchantment, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COSM or ENMI?
Cosmos Health, Inc. quarterly revenues are $17.1M, which are larger than DH Enchantment, Inc. quarterly revenues of $387.6K. Cosmos Health, Inc.'s net income of -$5.4M is lower than DH Enchantment, Inc.'s net income of -$124.9K. Notably, Cosmos Health, Inc.'s price-to-earnings ratio is -- while DH Enchantment, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cosmos Health, Inc. is 0.22x versus 0.29x for DH Enchantment, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COSMCosmos Health, Inc.0.22x -- $17.1M -$5.4M ENMIDH Enchantment, Inc.0.29x -- $387.6K -$124.9K
-
Which has Higher Returns COSM or GEGP?
Gold Entertainment Group, Inc. has a net margin of -31.29% compared to Cosmos Health, Inc.'s net margin of -44.6%. Cosmos Health, Inc.'s return on equity of -68.76% beat Gold Entertainment Group, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital COSMCosmos Health, Inc.13% -$0.17 $47.3M GEGPGold Entertainment Group, Inc.39.91% -- -$167.7K -
What do Analysts Say About COSM or GEGP?
Cosmos Health, Inc. has a consensus price target of $4.50, signalling upside risk potential of 836.72%. On the other hand Gold Entertainment Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cosmos Health, Inc. has higher upside potential than Gold Entertainment Group, Inc., analysts believe Cosmos Health, Inc. is more attractive than Gold Entertainment Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings COSMCosmos Health, Inc.0 0 0 GEGPGold Entertainment Group, Inc.0 0 0 -
Is COSM or GEGP More Risky?
Cosmos Health, Inc. has a beta of 4.381, which suggesting that the stock is 338.129% more volatile than S&P 500. In comparison Gold Entertainment Group, Inc. has a beta of 22.581, suggesting its more volatile than the S&P 500 by 2158.104%.
-
Which is a Better Dividend Stock COSM or GEGP?
Cosmos Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Gold Entertainment Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cosmos Health, Inc. pays -- of its earnings as a dividend. Gold Entertainment Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COSM or GEGP?
Cosmos Health, Inc. quarterly revenues are $17.1M, which are larger than Gold Entertainment Group, Inc. quarterly revenues of $42.6K. Cosmos Health, Inc.'s net income of -$5.4M is lower than Gold Entertainment Group, Inc.'s net income of -$19K. Notably, Cosmos Health, Inc.'s price-to-earnings ratio is -- while Gold Entertainment Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cosmos Health, Inc. is 0.22x versus 13.87x for Gold Entertainment Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COSMCosmos Health, Inc.0.22x -- $17.1M -$5.4M GEGPGold Entertainment Group, Inc.13.87x -- $42.6K -$19K
-
Which has Higher Returns COSM or LAB?
Standard BioTools, Inc. has a net margin of -31.29% compared to Cosmos Health, Inc.'s net margin of -162.05%. Cosmos Health, Inc.'s return on equity of -68.76% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital COSMCosmos Health, Inc.13% -$0.17 $47.3M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About COSM or LAB?
Cosmos Health, Inc. has a consensus price target of $4.50, signalling upside risk potential of 836.72%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 10.71%. Given that Cosmos Health, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Cosmos Health, Inc. is more attractive than Standard BioTools, Inc..
Company Buy Ratings Hold Ratings Sell Ratings COSMCosmos Health, Inc.0 0 0 LABStandard BioTools, Inc.1 2 0 -
Is COSM or LAB More Risky?
Cosmos Health, Inc. has a beta of 4.381, which suggesting that the stock is 338.129% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.264, suggesting its more volatile than the S&P 500 by 26.42%.
-
Which is a Better Dividend Stock COSM or LAB?
Cosmos Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cosmos Health, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COSM or LAB?
Cosmos Health, Inc. quarterly revenues are $17.1M, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Cosmos Health, Inc.'s net income of -$5.4M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Cosmos Health, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cosmos Health, Inc. is 0.22x versus 4.12x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COSMCosmos Health, Inc.0.22x -- $17.1M -$5.4M LABStandard BioTools, Inc.4.12x -- $19.6M -$31.7M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Sell
40
GDXU alert for Jan 31
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.
Sell
34
PFSI alert for Jan 31
PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.
Sell
40
SHNY alert for Jan 31
MicroSectors Gold 3X Leveraged ETN [SHNY] is down 31.56% over the past day.
